The global live cell encapsulation market was valued at USD 250 million in 2018 and is projected to reach USD 303 million by 2024, at a CAGR of 3.2% during the forecast period. The rising number of target patient population, increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical efficacy data of encapsulated cells in disease management are the major factors driving the growth of the live cell encapsulation market.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly